help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orio, F.
Right arrow Articles by Colao, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orio, F., Jr.
Right arrow Articles by Colao, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 8 3696-3701
Copyright © 2004 by The Endocrine Society

Special Feature

The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study

Francesco Orio, Jr., Stefano Palomba, Letizia Spinelli, Teresa Cascella, Libuse Tauchmanovà, Fulvio Zullo, Gaetano Lombardi and Annamaria Colao

Department of Molecular and Clinical Endocrinology and Oncology (F.O., T.C., L.T., G.L., A.C.) and Internal Medicine (L.S.), University Federico II, 80131 Naples, Italy; and Department of Obstetrics and Gynecology, University of Catanzaro (S.P., F.Z.), 88100 Catanzaro, Italy

Address all correspondence and requests for reprints to: Dr. Francesco Orio, Department of Molecular and Clinical Endocrinology and Oncology, University Federico II, Via S. Pansini 5, 80131 Naples, Italy. E-mail: francescoorio{at}virgilio.it.

To evaluate the cardiovascular risk of polycystic ovary syndrome (PCOS), we investigated lipid profile, metabolic pattern, and echocardiography in 30 young women with PCOS and 30 healthy age- and body mass index (BMI)-matched women. PCOS women had higher fasting glucose and insulin levels, homeostasis model assessment score of insulin sensitivity, total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) levels, and TC/high density lipoprotein cholesterol (HDL-C) ratio and lower HDL-C levels than controls. Additionally, PCOS women had higher left atrium size (32.0 ± 4.9 vs. 27.4 ± 2.1 mm; P < 0.0001) and left ventricular mass index (80.5 ± 18.1 vs. 56.1 ± 5.4 g/m2; P < 0.0001) and lower left ventricular ejection fraction (64.4 ± 4.1 vs. 67.1 ± 2.6%; P = 0.003) and early to late mitral flow velocity ratio (1.6 ± 0.4 vs. 2.1 ± 0.2; P < 0.0001) than controls. When patients and controls were grouped according to BMI [normal weight (BMI, >18 and <25 kg/m2), overweight (BMI, 25.1–30 kg/m2), and obese (BMI, >30 kg/m2)], the differences between PCOS women and controls were maintained in overweight and obese women. In normal weight PCOS women, a significant increase in left ventricular mass index and a decrease in diastolic filling were observed, notwithstanding no change in TC, LDL-C, HDL-C, TC/HDL-C ratio, and TG compared with controls. In conclusion, our data show the detrimental effect of PCOS on the cardiovascular system even in young women asymptomatic for cardiac disease.

We are grateful to Dr. Francesco Manguso (Department of Clinical and Experimental Medicine, Gastroenterology Unit, "Federico II" University, Naples, Italy) for his invaluable assistance in statistical analysis.

Abbreviations: BMI, Body mass index; CV, cardiovascular; CVD, CV disease; DBP, diastolic blood pressure; E/A, maximal early diastolic flow velocity/maximal late diastolic flow velocity ratio; EDV, end-diastolic volume; ESV, end-systolic volume; FAI, free androgen index; HDL-C, high density lipoprotein cholesterol; HOMA, homeostasis model assessment; LDL-C, low density lipoprotein cholesterol; LV, left ventricular; LVEF, LV ejection fraction; LVH, LV hypertrophy; LVM, LV mass; LVMi, LV mass index; PCOS, polycystic ovary syndrome; PRL, prolactin; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
E Carmina, E Guastella, R A Longo, G B Rini, and R A Lobo
Correlates of increased lean muscle mass in women with polycystic ovary syndrome
Eur. J. Endocrinol., October 1, 2009; 161(4): 583 - 589.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Rizzo, K. Berneis, M. Hersberger, I. Pepe, G. Di Fede, G. B. Rini, G. A. Spinas, and E. Carmina
Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype
Hum. Reprod., September 1, 2009; 24(9): 2286 - 2292.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Homburg
Androgen circle of polycystic ovary syndrome
Hum. Reprod., July 1, 2009; 24(7): 1548 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A.J. Goverde, A.J.B. van Koert, M.J. Eijkemans, E.A.H. Knauff, H.E. Westerveld, B.C.J.M. Fauser, and F.J. Broekmans
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria
Hum. Reprod., March 1, 2009; 24(3): 710 - 717.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel
The Metabolic Syndrome
Endocr. Rev., December 1, 2008; 29(7): 777 - 822.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. Rossi, S. Sukalich, J. Droz, A. Griffin, S. Cook, A. Blumkin, D. S. Guzick, and K. M. Hoeger
Prevalence of Metabolic Syndrome and Related Characteristics in Obese Adolescents with and without Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4780 - 4786.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Jensterle, M. Sebestjen, A. Janez, J. Prezelj, T. Kocjan, I. Keber, and M. Pfeifer
Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
Eur. J. Endocrinol., October 1, 2008; 159(4): 399 - 406.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. Kosmala, T. M. O'Moore-Sullivan, R. Plaksej, J. Kuliczkowska-Plaksej, M. Przewlocka-Kosmala, and T. H. Marwick
Subclinical Impairment of Left Ventricular Function in Young Obese Women: Contributions of Polycystic Ovary Disease and Insulin Resistance
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3748 - 3754.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. S. Guzick
Do Cardiovascular Risk Factors in Polycystic Ovarian Syndrome Result in More Cardiovascular Events?
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1170 - 1171.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
D. Glintborg, K. Hojlund, M. Andersen, J. E. Henriksen, H. Beck-Nielsen, and A. Handberg
Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
Diabetes Care, February 1, 2008; 31(2): 328 - 334.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Cascella, S. Palomba, I. De Sio, F. Manguso, F. Giallauria, B. De Simone, D. Tafuri, G. Lombardi, A. Colao, and F. Orio
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome
Hum. Reprod., January 1, 2008; 23(1): 153 - 159.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
O. Celik, I. Sahin, N. Celik, S. Hascalik, L. Keskin, H. Ozcan, A. Uckan, and F. Kosar
Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study
Hum. Reprod., November 1, 2007; 22(11): 2992 - 2998.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
F. Orio, F. Manguso, S. Di Biase, A. Falbo, F. Giallauria, D. Labella, A. Tolino, G. Lombardi, A. Colao, and S. Palomba
Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study
Eur. J. Endocrinol., July 1, 2007; 157(1): 69 - 73.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
E. Debing, E. Peeters, W. Duquet, K. Poppe, B. Velkeniers, and P. Van den Brande
Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy
Eur. J. Endocrinol., June 1, 2007; 156(6): 687 - 693.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M.-J. Chen, W.-S. Yang, J.-H. Yang, C.-L. Chen, H.-N. Ho, and Y.-S. Yang
Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
Hypertension, June 1, 2007; 49(6): 1442 - 1447.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
M.L. Hendriks, J.C.F. Ket, P.G.A. Hompes, R. Homburg, and C.B. Lambalk
Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome
Hum. Reprod. Update, May 1, 2007; 13(3): 249 - 264.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Vigorito, F. Giallauria, S. Palomba, T. Cascella, F. Manguso, R. Lucci, A. De Lorenzo, D. Tafuri, G. Lombardi, A. Colao, et al.
Beneficial Effects of a Three-Month Structured Exercise Training Program on Cardiopulmonary Functional Capacity in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1379 - 1384.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Berneis, M. Rizzo, V. Lazzaroni, F. Fruzzetti, and E. Carmina
Atherogenic Lipoprotein Phenotype and Low-Density Lipoproteins Size and Subclasses in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 186 - 189.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M.-J. Chen, W.-S. Yang, J.-H. Yang, C. K. Hsiao, Y.-S. Yang, and H.-N. Ho
Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
Hum. Reprod., September 1, 2006; 21(9): 2266 - 2271.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Orio Jr., F. Giallauria, S. Palomba, T. Cascella, F. Manguso, L. Vuolo, T. Russo, A. Tolino, G. Lombardi, A. Colao, et al.
Cardiopulmonary Impairment in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2967 - 2971.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A Dagre, J Lekakis, C Mihas, A Protogerou, L Thalassinou, D Tryfonopoulos, G Douridas, C Papamichael, and M Alevizaki
Association of dehydroepiandrosterone-sulfate with endothelial function in young women with polycystic ovary syndrome.
Eur. J. Endocrinol., June 1, 2006; 154(6): 883 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. Diamanti-Kandarakis, T. Paterakis, K. Alexandraki, C. Piperi, A. Aessopos, I. Katsikis, N. Katsilambros, G. Kreatsas, and D. Panidis
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
Hum. Reprod., June 1, 2006; 21(6): 1426 - 1431.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. L. Setji, N. D. Holland, L. L. Sanders, K. C. Pereira, A. M. Diehl, and A. J. Brown
Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1741 - 1747.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
E. Yesilada, I. Sahin, H. Ozcan, I. H. Yildirim, S. Yologlu, and C. Taskapan
Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome.
Eur. J. Endocrinol., April 1, 2006; 154(4): 563 - 568.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. I. Leibel, E. E. Baumann, M. Kocherginsky, and R. L. Rosenfield
Relationship of Adolescent Polycystic Ovary Syndrome to Parental Metabolic Syndrome
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1275 - 1283.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. C. Lewandowski, J. Komorowski, C. J. O'Callaghan, B. K. Tan, J. Chen, G. M. Prelevic, and H. S. Randeva
Increased Circulating Levels of Matrix Metalloproteinase-2 and -9 in Women with the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1173 - 1177.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. D. Coviello, R. S. Legro, and A. Dunaif
Adolescent Girls with Polycystic Ovary Syndrome Have an Increased Risk of the Metabolic Syndrome Associated with Increasing Androgen Levels Independent of Obesity and Insulin Resistance
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 492 - 497.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Urbanek, A. Woodroffe, K. G. Ewens, E. Diamanti-Kandarakis, R. S. Legro, J. F. Strauss III, A. Dunaif, and R. S. Spielman
Candidate Gene Region for Polycystic Ovary Syndrome on Chromosome 19p13.2
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6623 - 6629.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Orio Jr., S. Palomba, T. Cascella, B. De Simone, F. Manguso, S. Savastano, T. Russo, A. Tolino, F. Zullo, G. Lombardi, et al.
Improvement in Endothelial Structure and Function after Metformin Treatment in Young Normal-Weight Women with Polycystic Ovary Syndrome: Results of a 6-Month Study
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6072 - 6076.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Kravariti, K. K. Naka, S. N. Kalantaridou, N. Kazakos, C. S. Katsouras, A. Makrigiannakis, E. A. Paraskevaidis, G. P. Chrousos, A. Tsatsoulis, and L. K. Michalis
Predictors of Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5088 - 5095.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
B. Vural, E. Caliskan, E. Turkoz, T. Kilic, and A. Demirci
Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome
Hum. Reprod., September 1, 2005; 20(9): 2409 - 2413.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Azziz, C. Marin, L. Hoq, E. Badamgarav, and P. Song
Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4650 - 4658.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. B. Kilicdag, T. Bagis, E. Tarim, E. Aslan, S. Erkanli, E. Simsek, B. Haydardedeoglu, and E. Kuscu
Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial
Hum. Reprod., June 1, 2005; 20(6): 1521 - 1528.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. A. Ehrmann
Polycystic Ovary Syndrome
N. Engl. J. Med., March 24, 2005; 352(12): 1223 - 1236.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. S. Guzick
Cardiovascular Risk in PCOS
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3694 - 3695.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society